Publication Cover
Accountability in Research
Ethics, Integrity and Policy
Volume 29, 2022 - Issue 8
2,031
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Assuring data quality in investigator-initiated trials in dutch hospitals: Balancing between mentoring and monitoring

, , & ORCID Icon

References

  • Alingh, C. W., J. D. H. van Wijngaarden, J. Paauwe, and R. Huisman. 2015. “Commitment or Control: Patient Safety Management in Dutch Hospitals.” In New Clues for Analysing the HRM Black Box, edited by R. Valle-Cabrera and A. López-Cabrales, 97–124. Newcastle upon Tyne: Cambridge Scholars.
  • Angelique, H., K. Kyle, and E. Taylor. 2002. “Mentors and Muses: New Strategies for Academic Success.” Innovative Higher Education 26 (3): 195–209. doi:10.1023/A:1017968906264.
  • Apau Bediako, R., and C. Kaposy. 2020. “How Research Ethics Boards Should Monitor Clinical Research.” Accountability in Research 27 (1): 49–56. doi:10.1080/08989621.2019.1706048.
  • Baigent, C., F. E. Harrell, M. Buyse, J. R. Emberson, and D. G. Altman. 2008. “Ensuring Trial Validity by Data Quality Assurance and Diversification of Monitoring Methods.” Clinical Trials 5 (1): 49–55. doi:10.1177/1740774507087554.
  • Bhatt, A. 2011. “Quality of Clinical Trials: A Moving Target.” Perspectives in Clinical Research 2: 124–128. doi:10.4103/2229-3485.86880.
  • Blackwell, J. E. 1989. Mentoring: An Action Strategy for Increasing Minority Faculty. Academe 75: 8–14
  • Brosteanu, O., P. Houben, K. Ihrig, C. Ohmann, U. Paulus, B. Pfistner, G. Schwarz, A. Strenge-Hesse, and U. Zettelmeyer. 2009. “Risk Analysis and Risk Adapted On-site Monitoring in Noncommercial Clinical Trials.” Clinical Trials 6 (6): 585–596. doi:10.1177/1740774509347398.
  • Bussey-Jones, J., L. Bernstein, S. Higgins, D. Malebranche, A. Paranjape, I. Genao, L. Bennett, and W. Branch. 2006. “Repaving the Road to Academic Success: The IMeRGE Approach to Peer Mentoring.” Academic Medicine 81 (7): 674–679. doi:10.1097/01.ACM.0000232425.27041.88.
  • Cerullo, L., C. Radovich, I. Gandi, B. Widler, C. Stubbs, C. Riley-Wagenmann, R. McKellar, and P. K. Manasco. 2014. “Competencies for the Changing Role of the Clinical Study Monitor: Implementing A Risk-based Approach to Monitoring”. Applied Clinical Trials, April 29. Accessed 1 January 2021. http://www.appliedclinicaltrialsonline.com/competencies-changing-role-clinical-study-monitor-implementing-risk-based-approach-monitoring
  • Chilengi, R., G. N. Ogetii, and T. Lang. 2010. “A Sensible Approach to Monitoring Trials: Finding Effective Solutions In-house.” WebmedCentral Clinical Trials 1 (10): WMC00891.
  • Clutterbuck, D. 2014. Everyone needs a mentor. 5th ed. London: Chartered Institute of Personnel and Development
  • Connor, M., and J. Pokora. 2012. Coaching and Mentoring at Work: Developing Effective Practice. Berkshire: McGraw-Hill Education.
  • De Grauwe, A., and G. Carron. 2007. “Supervision: A Key Component of A Quality Monitoring System, Module 1.” In International Institute for Educational Planning, 1–33. Paris: UNESCO.
  • De Jong, J. P., M. C. van Zwieten, and D. L. Willems. 2013. “Research Monitoring by US Medical Institutions to Protect Human Subjects: Compliance or Quality Improvement?” Journal of Medical Ethics 39 (4): 236–241. doi:10.1136/medethics-2011-100434.
  • Edwards, P., H. Shakur, L. Barnetson, D. Prieto, S. Evans, and I. Roberts. 2014. “Central and Statistical Data Monitoring in the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2) Trial.” Clinical Trials 11 (3): 336–343. doi:10.1177/1740774513514145.
  • European Parliament and of the Council of the European Union. 2005. “Bovenkant Formulier Onderkant Formulier Commission Directive 2005/28/EC of 8 April 2005 Laying down Principles and Detailed Guidelines for Good Clinical Practice as Regards Investigational Medicinal Products for Human Use, as Well as the Requirements for Authorisation of the Manufacturing or Importation of Such Products.” Official Journal of European Union L91: 1–13. April. Accessed 31 January 2021. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2005:091:TOC
  • European Medicines Agency. 2013. Reflection Paper on Risk Based Quality Management in Clinical Trials. London: European Medicines Agency. Accessed 31 January 2021. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500155491.pdf
  • Frei, E., M. Stamm, and B. Buddeberg-Fischer. 2010. “Mentoring Programs for Medical Students: A Review of the PubMed Literature 2000–2008.” BMC Medical Education 10 (1): 32. doi:10.1186/1472-6920-10-32.
  • Glickman, S. W., J. G. McHutchison, E. D. Peterson, C. B. Cairns, R. A. Harrington, R. M. Califf, and K. A. Schulman. 2009. “Ethical and Scientific Implications of the Globalization of Clinical Research.” The New England Journal of Medicine 360 (8): 816–823. doi:10.1056/NEJMsb0803929.
  • Grit, K. J., and J. C. F. van Oijen. 2015. Toezicht Op Het Medisch-wetenschappelijk Onderzoek Met Mensen: Het in Kaart Brengen Van Een Multi-centered Speelveld [Supervision of Medical Research Involving Human Subjects: Mapping a Multi-centered Playing Field]. Rotterdam: iBMG, Erasmus Universiteit Rotterdam.
  • Heath, E. J. 1979. “The IRB’s Monitoring Function: Four Concepts of Monitoring.” IRB: Ethics & Human Research 1 (5): 1–3+12. doi:10.2307/3564385.
  • Heaton, C. 2000. “External Peer Review in Europe: An Overview from the ExPeRT Project.” International Journal for Quality in Health Care 12 (3): 177. doi:10.1093/intqhc/12.3.177.
  • Houston, L., Y. Probst, P. Yu, and A. Martin. 2018. “Exploring Data Quality Management within Clinical Trials.” Applied Clinical Informatics 9 (1): 072–081. doi:10.1055/s-0037-1621702.
  • Inspectie voor de Gezondheidszorg (IGJ), en Centrale Commissie Mensgebonden Onderzoek (CCMO) en Voedsel en Waren Autoriteit (NVWA). 2009. Onderzoek Naar De Propatria-studie: Lessen Voor Het Medisch-wetenschappelijk Onderzoek Met Mensen in Nederland [Research to the Propatria Study: Lessons for the Medical Research Involving Human Subject in the Netherlands]. Den Haag: IGJ, CCMO, en NVWA.
  • International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 1996. “ICH Harmonized Tripartite Guideline.” Guideline for Good Clinical Practice: Consolidated Guideline E6 (R1). June 10.
  • Jacobi, M. 1991. “Mentoring and Undergraduate Academic Success: A Literature Review.” Review of Educational Research 61: 505–532. doi:10.3102/00346543061004505.
  • Johnson, M. O., L. L. Subak, J. S. Brown, K. A. Lee, and M. D. Feldman. 2010. “An Innovative Program to Train Health Sciences Researchers to Be Effective Clinical and Translational-research Mentors.” Academic Medicine: Journal of the Association of American Medical Colleges 85 (3): 484–489. doi:10.1097/acm.0b013e3181cccd12.
  • Johnson, W. B. 2002. “The Intentional Mentor: Strategies and Guidelines for the Practice of Mentoring.” Professional Psychology: Research and Practice 33 (1): 88–96. doi:10.1037//0735-7028.33.1.88.
  • Keyser, D. J., J. M. Lakoski, S. Lara-Cinisomo, D. J. Schultz, V. L. Williams, D. F. Zellers, and H. A. Pincus. 2008. “Advancing Institutional Efforts to Support Research Mentorship: A Conceptual Framework and Self-assessment Tool.” Academic Medicine 83 (3): 217–225. doi:10.1097/ACM.0b13e318163700a.
  • Korenman, S. G. 2006. Teaching the Responsible Conduct of Research in Humans. Washington DC: Department of Health and Human Services, Office of Research Integrity, Responsible Conduct of Research Resources Development Program. Accessed 31 January 2021. https://ori.hhs.gov/education/products/ucla/default.htm
  • Kram, K. 1985. Mentoring at Work: Developmental Relationships in Organizational Life. Glenview, IL: Scott Foresman.
  • Kram, K. E., and L. A. Isabella. 1985. “Mentoring Alternatives: The Role of Peer Relationships in Career Development.” The Academy of Management Journal 28 (1): 110–132. doi:10.2307/256064.
  • Lavery, J. V., M. L. Van Laethem, and A. S. Slutsky. 2004. “Monitoring and Oversight in Critical Care Research.” Critical Care 8: 403. doi:10.1186/cc2964.
  • Manghani, K. 2011. “Quality Assurance: Importance of Systems and Standard Operating Procedures.” Perspectives in Clinical Research 2 (1): 34. doi:10.4103/2229-3485.76288.
  • McCusker, J., Z. Kruszewski, B. Lacey, and B. Schiff. 2001. “Monitoring Clinical Research: Report of One Hospital’s Experience.” Canadian Medical Association Journal len164 (9): 1321–1325.
  • McGee, R. 2016. “Biomedical Workforce Diversity: The Context for Mentoring to Develop Talents and Foster Success within the ‘Pipeline’.” AIDS and Behavior 20 (2): 231–237. doi:10.1007/s10461-016-1486-7.
  • Molloy, S. F., and P. Henley. 2016. “Monitoring Clinical Trials: A Practical Guide.” Tropical Medicine & International Health 21 (12): 1602–1611. doi:10.1111/tmi.12781.
  • Morrison, B. W., C. J. Cochran, J. G. White, J. Harley, C. F. Kleppinger, A. Liu, J. T. Mitchel, D. F. Nickerson, C. R. Zacharias, J. M. Kramer, et al. 2011. “Monitoring the Quality of Conduct of Clinical Trials: A Survey of Current Practices.” Clinical Trials 8 (3): 342–349. doi:10.1177/1740774511402703.
  • Morton-Cooper, A., and A. Palmer. 2000. Mentoring, Preceptor Ship and Clinical Supervision: A Guide to Professional Support Roles in Clinical Practice. 2nd ed. Oxford: Blackwell Science Ltd
  • Nederlandse Federatie van Universitair Medische Centra (NFU). 2012. Kwaliteitsborging Mensgebonden Onderzoek 2.0 [Quality Assurance of Research Involving Human Subjects 2.0]. Utrecht: NFU.
  • Nimmons, D., S. Giny, and J. Rosenthal. 2019. “Medical Student Mentoring Programs: Current Insights.” Advances in Medical Education and Practice 10: 113–123. doi:10.2147/AMEP.S154974.
  • Ochieng, J., J. Ecuru, F. Nakwagala, and P. Kutyabami. 2013. “Research Site Monitoring for Compliance with Ethics Regulatory Standards: Review of Experience from Uganda.” BMC Medical Ethics 14: 23. doi:10.1186/1472-6939-14-23.
  • Pfund, C., A. Byars-Winston, J. Branchaw, S. Hurtado, and K. Eagan. 2016. “Defining Attributes and Metrics of Effective Research Mentoring Relationships.” AIDS and Behavior 20 (Suppl 2): 238–248. doi:10.1007/s10461-016-1384-z.
  • Rabatin, J. S., M. Lipkin, A. S. Rubin, A. Schacter, M. Nathan, and A. Kalet. 2004. “A Year of Mentoring in Academic Medicine. Case Report and Qualitative Analysis of Fifteen Hours of Meetings between A Junior and Senior Faculty Member.” Journal of General Internal Medicine 19: 569–573. doi:10.1111/j.1525-1497.2004.30137.x.
  • Richards, C. E. 1998. “A Typology of Educational Monitoring Systems.” Educational Evaluation and Policy Analysis Summer 10 (2): 106–116. doi:10.3102/01623737010002106.
  • Shafiq, N., P. Pandhi, and S. Malhotra. 2009. “Investigator-initiated Pragmatic Trials in Developing Countries – Much Needed but Much Ignored.” British Journal of Clinical Pharmacology 67 (1): 141–142. doi:10.1111/j.1365-2125.2008.03291.x.
  • Shah, K. 2012. “A Day in the Life of A Monitor!” Perspectives in Clinical Research 3 (1): 32. doi:10.4103/2229-3485.92305.
  • Shetty, Y. C., K. S. Jadhav, A. A. Saiyed, and A. U. Desai. 2014. “Are Institutional Review Boards Prepared for Active Continuing Review?” Perspectives in Clinical Research 5 (1): 11–15. doi:10.4103/2229-3485.124553.
  • Stukart, M. J., E. T. M. Olsthoorn-Heim, S. van de Vathorst, A. van der Heide, K. Tromp, and C. de Klerk. 2012. Tweede Evaluatie Wet Medisch-wetenschappelijk Onderzoek Met Mensen [Second Evaluation of the Medical Research Involving Human Subjects Act]. Den Haag: ZonMw.
  • Tyndall, A. 2008. “Why Do We Need Noncommercial, Investigator-Initiated Clinical Trials?” Nature Clinical Practice Rheumatology 4 (7): 354–355. doi:10.1038/ncprheum0814.
  • US Food and Drug Administration. 2013. Guidance for Industry Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring. Accessed 31 January 2021. https://www.fda.gov/media/116754/download
  • Van Oijen, J., K. Grit, and R. Bal. 2016. “Investeer in Het Toezicht Op De Uitvoering Van Onderzoek! [Invest in Supervision on Conducting Research].” Podium Voor Bioethiek 23 (3): 31–35.
  • Van Oijen, J. C. F., I. Wallenburg, R. Bal, and K. J. Grit. 2020. “Institutional Work to Maintain, Repair, and Improve the Regulatory Regime: How Actors Respond to External Challenges in the Public Supervision of Ongoing Clinical Trials in the Netherlands.” PLoS ONE 15 (7): e0236545. doi:10.1371/journal.pone.0236545.
  • Walsh, M. K., J. J. McNeil, and K. J. Breen. 2005. “Improving the Governance of Health Research.” Medical Journal of Australia 182 (9): 468–471. doi:10.5694/j.1326-5377.2005.tb06788.x.
  • Weijer, C., S. Shapiro, A. Fuks, K. C. Glass, and M. Skrutkowska. 1995. “Monitoring Clinical Research: An Obligation Unfulfilled.” Canadian Medical Association Journal 152 (12): 1973–1980.
  • Zaat J., and P. De Leeuw. 2006. IGZ-Rapport over de Propatria Studie. Lessen voor Onderzoek. [IGJ-Report on the Propatria Study. Lessons for Research]Nederlands Tijdschrift voor Geneeskunde 2009 (153): B520.